Drug intelligence / Profile preview

ethylmethylthiambutene

Development stage
Unknown
Modality
Small Molecules
Administration
Oral
01

Overview

Ethylmethylthiambutene is a synthetic opioid analgesic of the thiambutene family. It is approximately 1.3 times as potent as morphine and acts primarily as an agonist at opioid receptors, especially the mu-opioid receptor. The drug produces strong analgesic effects but also carries a high risk of dependence and abuse similar to morphine. Ethylmethylthiambutene has been used for pain relief in both human and veterinary medicine, though it is now internationally controlled under Schedule I due to its abuse potential and lack of accepted medical use in many countries[2][4][5][7]. Its chemical structure features ethyl and methyl groups attached to a thiophene ring system.

Other names
emethibutinN-ethyl-N-methyl-1-methyl-3,3-di-2-thienylallylamine
02

Targets

KOR (Kappa opioid receptor)MOR (Mu opioid receptor)DOR (Opioid Receptor Delta 1)

Beyond the preview

Go deeper on ethylmethylthiambutene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ethylmethylthiambutene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call